SYED QADRI: Open Payments
NPI 1558432260 · FLORAL PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,055 in 39 payments from 14 companies in 2025. Trend: 2023 $998 · 2024 $2,015 · 2025 $1,055
Food & beverage: $1,055
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $233 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $169 |
| ABBVIE INC. | 4 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $118 |
| Kowa Pharmaceuticals America, Inc. | 4 | $78 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| PFIZER INC. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
Products named: JARDIANCE, Ozempic, XIFAXAN, RINVOQ, Wegovy, ZORYVE, VERQUVO, Kerendia.
Industry payments across NY — which companies pay providers there.
